BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies
BioNTech has reported a new technology that could overcome some of the most challenging issues…
12/06/2017 - 3 minutes
Antibodies
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal…
06/06/2017 - 2 minutes
Meet the Founder of the UK’s Best Biotech that Discovered Humira
Meet the founder of three hot British biotechs developing antibody-related technologies. Despite his interest in…
29/05/2017 - 9 minutes
Abcam Makes Final Payment in the Acquisition of an US Antibody Biotech
Abcam has paid US-based AxioMx a final €4.5M milestone based on performance, completing an acquisition…
18/05/2017 - 1 minute
AstraZeneca Misses the Mark in Late-Stage Asthma Trial
The UK pharma's antibody, tralokinumab, has failed to meet its primary endpoint in Phase III…
10/05/2017 - 2 minutes
Scottish Shark Antibodies have caught Amgen’s Eye
Elasmogen and its partner Feldan Therapeutics have signed a research agreement with Amgen to develop…
09/05/2017 - 2 minutes
The EU Approves New Treatment for a Rare Pediatric Cancer
Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic's APN311 in the…
08/05/2017 - 3 minutes
Unexpected Side Effects: Are we Ready for the Rise of Immunotherapies?
As immunotherapies are moving from large academic centers to clinics across the world, doctors are…
03/05/2017 - 4 minutes
How Biotech is Mastering Multiple Sclerosis: A Review
With last month’s FDA approval, Ocrevus (ocrelizumab), became the first drug for primary-progressive multiple sclerosis.…
25/04/2017 - 7 minutes
Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
13/04/2017 - 2 minutes
Janssen Stops Phase II Trial for a Danish Blood Cancer Blockbuster
Janssen and Genmab will not proceed to evaluate daratumumab as a treatment for non-Hodgkin's lymphoma since it…
31/03/2017 - 2 minutes
Get Ready for One of the Biggest New Drug Approvals of the Year
After Praluent, Sanofi and Regeneron have now scored their next drug approval with dupilumab, an antibody for the…
29/03/2017 - 3 minutes
